No unexpected safety issues have arisen to date, and the established safety profile for semaglutide is similar to that of other GLP-1RAs where definitive conclusions for pancreatic and thyroid cancer cannot be drawn at this point due to low incidence of these conditions
For the editorial, shorter version of this post, see The Quiet Way I Treat Aging: NAD Plus, GHK-Cu, and the Peptides I Stand Behind on drworldwide.com
Field, now age 43, had lost more than 100 pounds in two and a half years, and she says that the relief from food noise, a constant preoccupation with food, changed her life
it's about using it intelligently
The company also completed the acquisition of Scorpion Therapeutics mutant selective PI3K inhibitor program, strengthening its oncology pipeline